Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Jerrett K Lau"'
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0179755 (2017)
Pulmonary embolism continues to be a significant cause of death. The aim was to derive and validate a risk prediction model for in-hospital death after acute pulmonary embolism to identify low risk patients suitable for outpatient management.A confir
Externí odkaz:
https://doaj.org/article/219775248dca4a5989a031176eb22579
Autor:
Andy S C Yong, Ashkan Javadzadegan, William F Fearon, Abouzar Moshfegh, Jerrett K Lau, Stephen Nicholls, Martin K C Ng, Leonard Kritharides
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181824 (2017)
Discordance between angiography-based anatomical assessment of coronary stenosis severity and fractional flow reserve (FFR) has been attributed to several factors including lesion length and irregularity, and the myocardial territory supplied by the
Externí odkaz:
https://doaj.org/article/eb18dc249fdb43a49c3f6460c6e48e55
Autor:
Rong Bing, Vincent Chow, Jerrett K Lau, Liza Thomas, Leonard Kritharides, Austin Chin Chwan Ng
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0168554 (2016)
Acute pulmonary embolism (PE) carries an increased risk of death. Using transthoracic echocardiography (TTE) to assist diagnosis and risk stratification is recommended in current guidelines. However, its utilization in real-world clinical practice is
Externí odkaz:
https://doaj.org/article/ac09d817ab454d4d90cb808ec6c18eda
Autor:
Austin Chin Chwan Ng, Dona Adikari, David Yuan, Jerrett K Lau, Andy Sze Chiang Yong, Vincent Chow, Leonard Kritharides
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150448 (2016)
Symptomatic pulmonary embolism (PE) is a major cause of cardiovascular death and morbidity. Estimated prevalence and incidence of atrial fibrillation (AF) in developed countries are between 388-661 per 100,000, and 90-123 per 100,000 person-years res
Externí odkaz:
https://doaj.org/article/70fb22b2190c40b3998e3e70c1550e9c
Autor:
Christopher C. Y. Wong, Ashkan Javadzadegan, Cuneyt Ada, Jerrett K. Lau, Ravinay Bhindi, William F. Fearon, Leonard Kritharides, Martin K. C. Ng, Andy S. C. Yong
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 3 (2022)
Background The pathophysiological mechanism behind adverse outcomes associated with ischemia‐inducing epicardial coronary stenoses and microcirculatory dysfunction remains unclear. Wall shear stress (WSS) plays an important role in atherosclerotic
Externí odkaz:
https://doaj.org/article/f7c60bc27c194329a82d9c7abd2fedf2
Autor:
Erica S. Ghezzi, Peter J. Psaltis, Tobias Loetscher, Daniel Davis, Joseph Montarello, Jerrett K. Lau, Sinny Delacroix, Alice Bourke, James McLoughlin, Megan Keage, Hannah A. D. Keage
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Transcatheter aortic valve implantation (TAVI) has become the standard-of-care for treatment of severe symptomatic aortic stenosis and is also being increasingly recommended for low-risk patients. While TAVI boasts positive post-procedura
Externí odkaz:
https://doaj.org/article/270a5d14f9ee4a55b90a807e8fe1cde7
Autor:
Anthony C. Camuglia, Christopher M.W. Cole, Nicholas Boyne, Sam M. Hayman, Stephen V. Cox, Peter T. Moore, Jerrett K. Lau, Sinny Delacroix, Anna Emilie Williamson, MyNgan Duong, Nisha Schwarz, Joseph K. Montarello, Stephen G. Worthley
Publikováno v:
Heart, Lung and Circulation. 32:224-231
Transcatheter aortic valve implantation (TAVI) is an established therapy for the treatment of aortic valve disease in appropriately selected patients. Previous studies using the self-expanding Portico transcatheter heart valve (THV), (Abbott Structur
Autor:
Erica S. Ghezzi, Peter J Psaltis, Tobias Loetscher, Daniel Davis, Monique S Boord, Danielle Greaves, Joseph Montarello, Sinny Delacroix, Jerrett K Lau, Alice Bourke, James McLoughlin, Megan Keage, Hannah AD Keage
Background Transcatheter aortic valve implantation (TAVI) has become the standard for treating severe symptomatic aortic stenosis in those with prohibitive surgical risk. Cognitive complications, including delirium and cognitive decline are common fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a41ab248530974c81a4a6df25241d88
https://hdl.handle.net/11541.2/34511
https://hdl.handle.net/11541.2/34511
Autor:
Jerrett K. Lau, Probal Roy, Ashkan Javadzadegan, Abouzar Moshfegh, William F. Fearon, Martin Ng, Harry Lowe, David Brieger, Leonard Kritharides, Andy S. Yong
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 19 (2018)
Background Remote ischemic preconditioning (RIPC) attenuates myocardial damage during elective and primary percutaneous coronary intervention. Recent studies suggest that coronary microcirculatory function is an important determinant of clinical outc
Externí odkaz:
https://doaj.org/article/67ee8f60a3dd4674bf3628a417f702c6
Autor:
Heather Campbell, Gabrielle J. Pennings, Leonard Kritharides, Vivien M. Chen, Andy S.C. Yong, Jerrett K. Lau, Mathew Traini, Hai Po H. Liang, Elizabeth E. Gardiner, Caroline J. Reddel
Publikováno v:
Journal of Thrombosis and Haemostasis. 18:1221-1232
OBJECTIVES We investigated whether remote ischemic preconditioning (RIPC) inhibits agonist-induced conformational activation of platelet αIIb β3 in patients with coronary artery disease already receiving conventional antiplatelet therapy. PATIENTS/